Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages

…, L Caione, V Cepero, P Conrotto, A Cignetti… - The Journal of …, 2008 - rupress.org
Increased evidence suggests that cancer-associated inflammation supports tumor growth
and progression. We have previously shown that semaphorin 4D (Sema4D), a ligand …

Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers

…, RA Nash, M Aglietta, A Cignetti - International …, 2008 - academic.oup.com
Donor-derived cytokine-induced killer (CIK) can be infused as adoptive immunotherapy
after hematopoietic cell transplant (HCT). Promising results were recently reported in HLA-…

Chronic myeloid leukemia stem cells

…, G Simonetti, P Circosta, V Gaidano, A Cignetti… - Leukemia, 2019 - nature.com
Chronic myeloid leukemia (CML) is caused by BCRABL1 in a cell with the biological potential,
intrinsic or acquired, to cause leukemia. This cell is commonly termed the CML leukemia …

The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment

…, M Mazzone, A Vallario, A Cignetti… - The Journal of …, 2008 - rupress.org
Semaphorins are a large family of evolutionarily conserved morphogenetic molecules
originally identified for their repelling role in axonal guidance. Intriguingly, semaphorins have …

High basal γH2AX levels sustain self-renewal of mouse embryonic and induced pluripotent stem cells

…, K Moorwood, P Circosta, A Cignetti… - stem cells, 2012 - academic.oup.com
Phosphorylation of histone H2AX (γH2AX) is known to be the earliest indicator of DNA
double-strand breaks. Recently, it has been shown that mouse embryonic stem cells (mESCs) …

Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors

…, D Bonanni, B Rolando, A Cignetti… - Journal of medicinal …, 2018 - ACS Publications
Human dihydroorotate dehydrogenase (hDHODH) catalyzes the rate-limiting step in de novo
pyrimidine biosynthesis, the conversion of dihydroorotate to orotate. hDHODH has recently …

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian …

…, M Cerrano, S D'Ardia, E Audisio, A Cignetti… - Blood Cancer …, 2020 - nature.com
Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and
allogeneic stem cell transplantation (HSCT). We evaluated toxicity and efficacy of CPX-351 …

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

…, I Iacobucci, G Martinelli, A Cignetti… - Blood, The Journal …, 2015 - ashpublications.org
The analyses carried out using 2 different bioinformatics pipelines (SomaticSniper and
MuTect) on the same set of genomic data from 133 acute myeloid leukemia (AML) patients, …

Targeting chronic myeloid leukemia stem/progenitor cells using venetoclax-loaded immunoliposome

…, F Garello, R Stefania, V Gaidano, A Cignetti… - Cancers, 2021 - mdpi.com
Simple Summary Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent
population that are resistant to tyrosine kinase inhibitors. CML LSCs have many features in …

Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses

A Cignetti, A Vallario, I Roato, P Circosta… - The Journal of …, 2004 - journals.aai.org
Primary acute myeloid leukemia cells can be induced to differentiate into dendritic cells (DC).
In the presence of GM-CSF, TNF-α, and/or IL-4, leukemia-derived DC are obtained that …